HK1041636A1 - 含大豆蛋白、食用纖維及植物性雌激素混合物的成份，以及使用上述成份預防及/或治療第二類糖尿病、新陳代謝綜合症及有關的心血管疾病 - Google Patents

含大豆蛋白、食用纖維及植物性雌激素混合物的成份，以及使用上述成份預防及/或治療第二類糖尿病、新陳代謝綜合症及有關的心血管疾病

Info

Publication number
HK1041636A1
HK1041636A1 HK02101699.0A HK02101699A HK1041636A1 HK 1041636 A1 HK1041636 A1 HK 1041636A1 HK 02101699 A HK02101699 A HK 02101699A HK 1041636 A1 HK1041636 A1 HK 1041636A1
Authority
HK
Hong Kong
Prior art keywords
composition
soy protein
diabetes
cardiovascular diseases
dietary fibres
Prior art date
Application number
HK02101699.0A
Other languages
English (en)
Inventor
Henrik Hoie Lars
Original Assignee
Nutri Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26064784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1041636(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutri Pharma As filed Critical Nutri Pharma As
Publication of HK1041636A1 publication Critical patent/HK1041636A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK02101699.0A 1998-11-25 2002-03-05 含大豆蛋白、食用纖維及植物性雌激素混合物的成份，以及使用上述成份預防及/或治療第二類糖尿病、新陳代謝綜合症及有關的心血管疾病 HK1041636A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199801556 1998-11-25
DKPA199900856 1999-06-16
PCT/IB1999/001992 WO2000030663A1 (en) 1998-11-25 1999-11-25 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases

Publications (1)

Publication Number Publication Date
HK1041636A1 true HK1041636A1 (zh) 2002-07-19

Family

ID=26064784

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101699.0A HK1041636A1 (zh) 1998-11-25 2002-03-05 含大豆蛋白、食用纖維及植物性雌激素混合物的成份，以及使用上述成份預防及/或治療第二類糖尿病、新陳代謝綜合症及有關的心血管疾病

Country Status (9)

Country Link
EP (1) EP1143988B1 (zh)
JP (1) JP2003524610A (zh)
AT (1) ATE259646T1 (zh)
AU (1) AU1511300A (zh)
BR (1) BR9915693A (zh)
CA (1) CA2352510A1 (zh)
DE (1) DE69914947D1 (zh)
HK (1) HK1041636A1 (zh)
WO (1) WO2000030663A1 (zh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592910B1 (en) 1999-04-20 2003-07-15 Board Of Trustees, Southern Illinois University Methods of treating clinical diseases with isoflavones
AU779014B2 (en) * 1999-04-23 2005-01-06 Archer-Daniels-Midland Company Composition for and method of reducing low density lipoprotein cholesterol concentration
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
AU783820B2 (en) * 1999-04-23 2005-12-08 Archer-Daniels-Midland Company Composition for and method of reducing low density lipoprotein cholesterol concentration
US7285297B1 (en) 1999-04-23 2007-10-23 Archer-Daniels-Midland Company Method of reducing low density liproprotein cholesterol concentration
ATE439051T1 (de) 2000-04-14 2009-08-15 Mars Inc Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
JP2011105763A (ja) * 2000-06-21 2011-06-02 Kao Corp Ｐｐａｒ依存的遺伝子転写活性化剤
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
AU2001279593A1 (en) * 2001-02-01 2002-08-12 Soren Gregersen A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
FI20010780A0 (fi) 2001-04-12 2001-04-12 Raisio Benecol Oy Parannetut koostumukset
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
EP1443946A2 (en) * 2001-07-03 2004-08-11 Nutri Pharma ASA Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
GB0125662D0 (en) * 2001-10-26 2001-12-19 Chapman Thomas B Formultion
AU2003206050A1 (en) * 2002-02-22 2003-09-09 Nutri Pharma Asa Food products comprising soy protein
WO2003070007A2 (en) * 2002-02-23 2003-08-28 Nutri Pharma Asa Method for manufacturing beads containing exogenous soy protein
EP1480525A2 (en) * 2002-02-23 2004-12-01 Nutri Pharma ASA Novel soy protein products
CN102240040B (zh) 2002-04-18 2014-12-24 孟山都技术有限公司 用于减少心血管疾病风险的油体缔合蛋白质的组合物和方法及其用途
EP1545206B1 (en) 2002-07-24 2020-03-04 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
WO2004039327A2 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
JP2008007452A (ja) * 2006-06-28 2008-01-17 Ajinomoto Co Inc 膵β細胞保護剤
EP2060263A4 (en) * 2006-08-21 2012-01-25 Calpis Co Ltd AGENT FOR IMPROVING LIPID METABOLISM
DE102006040456A1 (de) * 2006-08-25 2008-02-28 Constantin Nies Verzehrbare flächige Darreichungsform von Nahrungsergänzungsmitteln und/oder Arzneiwirkstoffen zur Ergänzung von fertigen oder halbfertigen Nahrungsmitteln
US9101161B2 (en) 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
CN102919739B (zh) 2007-06-13 2014-07-02 大塚制药株式会社 含雌马酚的提取物、其制备方法、雌马酚的提取方法及含雌马酚的食品
JP2011006369A (ja) * 2009-06-29 2011-01-13 Kao Corp Ｐａｉ−１低下剤
US10631564B2 (en) 2015-06-19 2020-04-28 University Of Southern California Enterically coated microparticle compositions and methods for modified nutrient delivery
US10744070B2 (en) 2015-06-19 2020-08-18 University Of Southern California Enteral fast access tract platform system
USD767242S1 (en) 2015-09-03 2016-09-27 The J.M Smucker Company Coated food product
USD767241S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767243S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767244S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
WO2021064107A1 (en) 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395288A1 (fr) * 1977-06-23 1979-01-19 Ppn Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore
DK171752B1 (da) * 1992-07-06 1997-05-12 Birgitte Stilling Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
WO1997037547A1 (en) * 1996-04-09 1997-10-16 E.I. Du Pont De Nemours And Company Novel isoflavone-enriched soy protein product and method for its manufacture
AU3887597A (en) * 1996-07-18 1998-02-10 Nutricor, Inc. Nutritious food preparations and methods for making them
DE69837821T3 (de) * 1997-06-23 2015-05-28 Société des Produits Nestlé S.A. Zusammensetzung zur Ernährung von Diabetikern

Also Published As

Publication number Publication date
AU1511300A (en) 2000-06-13
BR9915693A (pt) 2001-08-14
ATE259646T1 (de) 2004-03-15
DE69914947D1 (de) 2004-03-25
WO2000030663A1 (en) 2000-06-02
CA2352510A1 (en) 2000-06-02
EP1143988A1 (en) 2001-10-17
EP1143988B1 (en) 2004-02-18
JP2003524610A (ja) 2003-08-19

Similar Documents

Publication Publication Date Title
HK1041636A1 (zh) 含大豆蛋白、食用纖維及植物性雌激素混合物的成份，以及使用上述成份預防及/或治療第二類糖尿病、新陳代謝綜合症及有關的心血管疾病
HK1041635A1 (zh) 含大豆蛋白，食用纖維及植物性雌激素混合物的成份，以及使用上述成份預防及/或治療心血管疾病
HK1041634A1 (zh) 含大豆蛋白、食用纖維及植物性雌激素混合物的成份，以及使用上述成份預防及/或治療肺部疾病
CA2231292A1 (en) Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
CA2266318A1 (en) Flavonol containing food supplements
PL338034A1 (en) Nourishing composition for treating bedsores
WO1999004748A3 (en) Skin care composition
NO983971D0 (no) Preparat og dets anvendelse som næringstilskudd eller for å redusere lipider i serum
ES2152072T3 (es) Compuesto nutritivo mejorado resultado de la maceracion de maiz y su procedimiento de obtencion.
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
EP1025850A4 (en) COMPOSITIONS CONTAINING ISOFLAVONE
WO2004043176A3 (de) Socke
NZ502610A (en) Use of lactobacillus for reduction of the fibrinogen level in blood
FI973867A (fi) Viljaruokavalmiste, jossa on runsaasti liukoista kuitua
PT1056357E (pt) Composicao nutricional altamente calorica
EP0824152A3 (en) Microbial production of vitamin B12 and production and use of compositions comprising high concentrations of vitamin B12 activity
GB9613070D0 (en) Dietary lectins
CA2371896A1 (en) Method of increasing the content of flavonoids and phenolic substances in plants
EP1167016A3 (en) Oxygen absorbable laminate and production method thereof
ATE377960T1 (de) Nährungszusammensetzung für sport
TR200002894T2 (tr) L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon
BG103543A (en) The use of pramipexol in the treatment of the uneasy legs syndrome
MD980129A (en) Antiherpetic remedy
CA2182157A1 (en) Composition for a Dietary Supplement for the Treatment of Hemorrhoids
AU2003230830A1 (en) Treatment of type 1 diabetes before and after expression of predisposition markers